Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$1.22B |
| 3 |
Progressive
PGR
|
+$1.12B |
| 4 |
Exelon
EXC
|
+$977M |
| 5 |
Pfizer
PFE
|
+$713M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.5B |
| 2 |
Boston Scientific
BSX
|
+$723M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$709M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$590M |
| 5 |
Expedia Group
EXPE
|
+$558M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.74% |
| 2 | Financials | 15.42% |
| 3 | Technology | 14.93% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
W.P. Carey
WPC
$16.8B
| $718K | ﹤0.01% |
9,156
+1,723
| +23% | +$144K |
|
|
CMD
1752
DELISTED
Cantel Medical Corporation
CMD
| $718K | ﹤0.01% |
10,129
-12,393
| -55% | -$899K |
|
1753
10x Genomics
TXG
$6B
| $699K | ﹤0.01% |
9,169
-66,458
| -88% | -$4M |
|
1754
Warner Bros
WBD
$65.9B
| $696K | ﹤0.01% |
21,254
-123,615
| -85% | -$3.72M |
|
1755
Constellium
CSTM
$3.76B
| $695K | ﹤0.01% |
51,858
+36,433
| +236% | +$503K |
|
|
KYNB
1756
Kyntra Bio
KYNB
$27.2M
| $693K | ﹤0.01% |
647
+129
| +25% | +$132K |
|
1757
First Business Financial Services
FBIZ
$587M
| $691K | ﹤0.01% |
26,243
-4,308
| -14% | -$107K |
|
|
DEA
1758
Easterly Government Properties
DEA
$1.13B
| $689K | ﹤0.01% |
11,610
+1,608
| +16% | +$90.7K |
|
|
ENV
1759
DELISTED
ENVESTNET, INC.
ENV
| $688K | ﹤0.01% |
9,888
-8,638
| -47% | -$562K |
|
1760
Asbury Automotive
ABG
$4.31B
| $676K | ﹤0.01% |
6,046
-2,519
| -29% | -$271K |
|
1761
Atkore
ATKR
$2.46B
| $676K | ﹤0.01% |
16,723
-5,498
| -25% | -$203K |
|
1762
Bloomin' Brands
BLMN
$741M
| $671K | ﹤0.01% |
+30,403
| New | +$645K |
|
1763
Royal Caribbean
RCL
$85.1B
| $665K | ﹤0.01% |
4,982
-278,204
| -98% | -$32.4M |
|
1764
NeoGenomics
NEO
$1.96B
| $664K | ﹤0.01% |
22,696
-86,062
| -79% | -$2.05M |
|
1765
Editas Medicine
EDIT
$396M
| $660K | ﹤0.01% |
+22,299
| New | +$557K |
|
|
PLAN
1766
DELISTED
Anaplan, Inc.
PLAN
| $649K | ﹤0.01% |
+12,377
| New | +$614K |
|
1767
Graco
GGG
$12.9B
| $648K | ﹤0.01% |
12,465
-101,394
| -89% | -$4.84M |
|
1768
BRC Group Holdings
RILY
$288M
| $645K | ﹤0.01% |
25,623
-748
| -3% | -$19.7K |
|
|
ESPR
1769
DELISTED
Esperion Therapeutics
ESPR
| $642K | ﹤0.01% |
+10,773
| New | +$484K |
|
1770
Tractor Supply
TSCO
$16.1B
| $640K | ﹤0.01% |
34,235
-105,815
| -76% | -$2.01M |
|
|
EPZM
1771
DELISTED
Epizyme, Inc
EPZM
| $636K | ﹤0.01% |
+25,869
| New | +$384K |
|
1772
Graham Holdings Company
GHC
$5.18B
| $634K | ﹤0.01% |
993
-2,012
| -67% | -$1.29M |
|
1773
Bank of Hawaii
BOH
$3.15B
| $630K | ﹤0.01% |
+6,622
| New | +$589K |
|
|
MNR
1774
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $624K | ﹤0.01% |
43,092
-1,257
| -3% | -$18.6K |
|
1775
iShares Core S&P 500 ETF
IVV
$878B
| $622K | ﹤0.01% |
1,925
| – | – |
|
Similar funds
Wellington Management Group's Q4 2019 Portfolio in Review
As of Q4 2019, Wellington Management Group held 2,205 positions worth $477B, up 7.6% from $443B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wellington Management Group's Q4 2019 filing shows 192 new, 703 increased, 960 reduced and 204 closed positions. Its largest new stake was Zoom: 2,196,622 shares worth $149M. The largest sale was Bristol-Myers Squibb, an estimated $1.5B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q4 2019 buy was Zoom: 2,196,622 shares worth $149M.
- Wellington Management Group added most to Apple in Q4 2019, an estimated $2.3B increase.
- Wellington Management Group's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.5B.
- Wellington Management Group fully exited Genesee & Wyoming Inc. in Q4 2019, selling an estimated $365M.
- Wellington Management Group's ten largest holdings make up 16% of its $477B portfolio in Q4 2019.
- Wellington Management Group opened 192 new positions and closed 204 in Q4 2019.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $477B.
Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.